Oceanía · Actualidad · The Mercury

Argent BioPharma sets four priorities as it eyes healthy ageing research

Publicado por The Mercury · Australia hace 12 h

Argent BioPharma (ASX:RGT) has listed four strategic priorities following the global licensing of CannEpil, expansion of its pharmaceutical development programs and continued…

Leer el artículo completo en The Mercury Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.themercury.com.au)

Argent BioPharma sets four priorities as it eyes healthy ageing research

También te puede interesar

'Extreme' sect reported years before young girl's death

King River goes deep with 11,000m WA Murchison gold assault

This economist believes the system is broken. Maybe she has a point

Senior police officer facing sack over claims of rough, non-consensual sex

Senior police officer facing sack over claims of rough, non-consensual sex

The words that should haunt Canberrans in the wake of this awful sentencing

Argent BioPharma sets four priorities as it eyes healthy ageing research

Compartir

También te puede interesar

'Extreme' sect reported years before young girl's death

King River goes deep with 11,000m WA Murchison gold assault

This economist believes the system is broken. Maybe she has a point

Senior police officer facing sack over claims of rough, non-consensual sex

Senior police officer facing sack over claims of rough, non-consensual sex

The words that should haunt Canberrans in the wake of this awful sentencing